DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Pyrazinamide (Pyrazinamide) - Summary

 


Nutrilib.com
A comprihensive source of nutritional information

PYRAZINAMIDE SUMMARY

PYRAZINAMIDE TABLETS USP
mg

Pyrazinamide, the pyrazine analogue of nicotinamide, is an antituberculous agent. It is a white crystalline powder, stable at room temperature, and sparingly soluble in water.

Pyrazinamide is indicated for the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents. (The current recommendation of the CDC for drugsusceptible disease is to use a six-month regimen for initial treatment of active tuberculosis, consisting of isoniazid, rifampin and pyrazinamide given for 2 months, followed by isoniazid and rifampin for 4 months.*4)

(Patients with drug-resistant disease should be treated with regimens individualized to their situation. Pyrazinamide frequently will be an important component of such therapy.)

(In patients with concomitant HIV infection, the physician should be aware of current recommendation of CDC. It is possible these patients may require a longer course of treatment)

It is also indicated after treatment failure with other primary drugs in any form of active tuberculosis.

Pyrazinamide should only be used in conjunction with other effective antituberculous agents.

*See recommendations of Center for Disease Control (CDC) and American Thoracic Society for complete regimen and dosage recommendations.4


See all Pyrazinamide indications & dosage >>

PYRAZINAMIDE NEWS HIGHLIGHTS

Media Articles Related to Pyrazinamide

100,000 Saved From Dying Of Tuberculosis
Source: Aid / Disasters News From Medical News Today [2008.11.15]

Tuberculosis Skin Test (PPD Skin Test)
Source: MedicineNet Tuberculosis Specialty [2008.09.02]

Tuberculosis
Source: MedicineNet Erythema Nodosum Specialty [2008.01.17]

Extensively Drug-Resistant Tuberculosis (XDR TB)
Source: MedicineNet ICU Psychosis Specialty [2007.05.30]

Carla Bruni joins fight against AIDS (AFP)
Source: Y! Health HIV & AIDS News [2008.11.27]

more >>

Published Studies Related to Pyrazinamide

Pyrazinamide blood concentrations in children suffering from tuberculosis: a comparative study at two doses. [2008.03]

Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis. [2007.02.07]

Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts. [2006.04.15]

Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus? [2005.03]

more >>

Clinical Trials Related to Pyrazinamide

TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment [Completed]

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection [Active, not recruiting]

Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection [Completed]

Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis [Not yet recruiting]

Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis [Active, not recruiting]

more >>

Page last updated: 2008-11-27

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008